Top Buy
| Security | Buy | Sell | Buy (1W) ▲ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 29 | 0 | 0 | 0 | €129.15 | €140.60 | 8.868% |
| AnaptysBio Inc | 8 | 1 | 0 | 0 | €22.00 | €45.21 | 105.500% |
| Sangamo Therapeutics Inc. | 12 | 12 | 0 | 0 | €0.57 | €3.63 | 536.590% |
| SCYNEXIS Inc. | 5 | 0 | 0 | 0 | €2.16 | €8.35 | 287.062% |
| Lexicon Pharmaceuticals Inc. | 2 | 0 | 0 | 0 | €1.46 | €5.34 | 265.229% |
| Immunogen Inc. | 5 | 0 | 0 | 0 | €28.97 | - | - |
| Insmed Inc. | 18 | 1 | 0 | 1 | €21.20 | €44.16 | 108.325% |
| Rigel Pharmaceutical Inc. | 10 | 0 | 0 | 0 | €0.84 | €13.77 | 1548.474% |
| Actinium Pharmaceuticals Inc. | 3 | 0 | 0 | 0 | €7.83 | €10.00 | 27.796% |
| Amneal Pharmaceuticals Inc | 1 | 1 | 0 | 0 | €5.95 | €10.00 | 68.067% |
| Catalent Inc. | 1 | 0 | 0 | 0 | €49.76 | €55.00 | 10.531% |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | €18.60 | €45.10 | 142.446% |
| Intellia Therapeutics Inc | 13 | 1 | 0 | 0 | €22.65 | €60.55 | 167.347% |
| AbbVie Inc. | 22 | 0 | 0 | 0 | €144.88 | €175.11 | 20.866% |
| Merck KGaA | 3 | 1 | 0 | 0 | €168.00 | €146.00 | -13.095% |
| Avadel Pharmaceuticals plc ADR | 1 | 0 | 0 | 0 | €15.10 | €23.00 | 52.318% |
| Novartis AG ADR | 1 | 0 | 0 | 0 | €92.80 | - | - |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €113.80 | €130.00 | 14.236% |
| Repligen Corp. | 13 | 0 | 0 | 0 | €144.70 | €184.76 | 27.685% |
| Biocryst Pharmaceuticals | 9 | 0 | 0 | 0 | €5.73 | €11.05 | 92.796% |
| Fagron N.V. | 1 | 0 | 0 | 0 | €18.34 | €20.00 | 9.051% |
| TG Therapeutics Inc. | 22 | 4 | 0 | 0 | €15.06 | €28.06 | 86.327% |
| Apellis Pharmaceuticals | 3 | 0 | 0 | 0 | €37.30 | €70.00 | 87.668% |
| Eli Lilly Corp. | 49 | 0 | 0 | 0 | €748.70 | €776.16 | 3.668% |
| Sanofi S.A. ADR | 9 | 0 | 0 | 0 | €44.80 | - | - |